✦ LIBER ✦

Amsacrine containing induction therapy in elderly AML patients: Comparison to standard induction regimens in a matched-pair analysis

✍ Scribed by T. Kessler; M. Mohr; C. Müller-Tidow; U. Krug; U. Brunnberg; B. Mohr; C. Schliemann; C. Sauerland; H. Serve; T. Büchner; W.E. Berdel; R.M. Mesters

Book ID: 104040482
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 141 KB
Volume: 32
Category: Article
ISSN: 0145-2126
DOI: 10.1016/j.leukres.2007.06.015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized multicenter open label phas

A randomized multicenter open label phase II study to determine the safety and efficacy of induction therapy with imatinib (Glivec, formerly STI571) in comparison with standard induction chemotherapy in elderly (>55

✍ B. Wassmann; N. Gökbuget; U.J. Scheuring; A. Binckebanck; R. Reutzel; H. Gschaid 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 176 KB

Fludarabine increases complete response

Fludarabine increases complete response but not survival compared with conventional alkylator-based regimens for previously untreated chronic lymphocytic leukaemia: Abstracted from: Zhu Q, Tan DCL, Samuel M, Chan ESY, Linn YC. Fludarabine in comparison to alkylator-based regimen as induction therapy for chronic lymphocytic leukaemia: A systematic review and meta-analysis. Leukaemia Lymphoma 2004; 45:2239–45.

✍ Sue Richards 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 79 KB